| Tag | Content |
|---|
EnhancerAtlas ID | HS184-13865 |
Organism | Homo sapiens |
Tissue/cell | T47D |
Coordinate | chr17:54857190-54858230 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr17:54857745-54857764 | CACTGACCCCTAGTGGCCG | - | 6.93 | | Lhx3 | MA0135.1 | chr17:54857629-54857642 | CATTAATTAATTT | - | 6.54 | | POU6F1 | MA0628.1 | chr17:54857630-54857640 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr17:54857630-54857640 | ATTAATTAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_39637 | chr17:54856470-54857706 | Jurkat | | SE_39637 | chr17:54857777-54858905 | Jurkat | | SE_66571 | chr17:54856470-54857706 | Jurkat | | SE_66571 | chr17:54857777-54858905 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I056779 | chr17 | 54856485 | 54859506 |
|
Enhancer Sequence | CAGGAAAGTG AAGAGAGAGA GAGATTATAC AGGGTTTTTT TTTTTTTCCT TCAAAGTGTC 60
TCCTCTGCAG ACGCCTGGTG CAGCTCTGTC TCCGGGGAGC GGTTCACCCT CCAGAAAATA 120
TGACACTTTA TTTCCTGCCC TTGTTTGCTA ACACACCCCA TTACCATCCA TCTCAGTTTC 180
ATGTAACTGC CAACCGGCAT TAACGCCCTC CTCCTCGCCG AGGCAGAAAA TAGAAAAGGA 240
AGAATTCAGC AGATTTTCCC CGGTGGCCCC CTCGGCGGCA CCAAGATAAC CAGCGCAGAA 300
ACCACAATTG GATCCTTATT CCTCCAGCCC AGGAATGCGA AGGACGGGAC GGTTTAACCG 360
CCTTCTGCAT TTTCCTGCAA AGAGAGCCGG CTTGTTATTT CGGTTGTCTG GGCTCCCTTC 420
TTTACTACGG AGAAAGATAC ATTAATTAAT TTTTTTTTTT AATGTTAGGC AGGAAATGTT 480
GCAAACTGTC AAGAGCTGTC AGCGGGCGCC TGCCCCAATC AGGTAAGCGG CGCGCGGGCG 540
CCTGCGGCGG AGACACACTG ACCCCTAGTG GCCGACCGGG CCCTCGCAGC CCCCGCGCCC 600
GCCCTCGCTC CGGGCGGCCA GAGTCGCAGT CAAGTCGCTC TTTGCACAGA GCAGCTCTGT 660
GTGGACTGGC GGGGGTGTGG CCGGTGCTGT GTCTCCACCG CCCGCCCCAA CGCAAGCACG 720
CGCGCACATA CACCCCATGT CCATTTGCTC TTCCAAACCA GAGAAGCAAT TTCTGCTCTC 780
CTTGTCCAAT TCCAGAGAAC ACAGATGCCT GAGAACCTTA AGCAGTGTGC CTCTGTGCTG 840
TTGCTCAGGC ATGTGCCTCT GCTCTTGAGG AGTGACGGGA AAGACAGACA GGGTCCCAGT 900
GTGACACAGG GCTGAGAGGA AGGAAGGGGG TGGCGTTTGT GGAGACTCCC AGTACCAGAC 960
ACTGTGCACA CGGTTATCCC TTGGAGCCTG ATGATAGCCC CAGATTTGGA AACTGAGGCC 1020
CCAGCTGTCA CATGGCTTGT 1040
|
